Want to join the conversation?
$DOV 2Q15 Q&A: Davis of Barclays asked about corporate expense and Brad answered that half is comp related and other half, about 50% of that, is real cost takeout. He added that that is related to the functional cost initiatives around reducing corporate overhead and there is a miscellaneous other stuff that normally happens in any given quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?